H&F Corporate Investors X, Ltd.
•CIK: 1901930•Filing: Q4 2025
H&F Corporate Investors X, Ltd., managed by the seasoned team at H&F Management, currently holds a concentrated portfolio with 100% of its $4.2 billion AUM in Moderna (MDLN), reflecting a high-conviction, single-stock strategy. The fund recently exited its position in Salesforce (SPLK), indicating a strategic shift towards biotech, aligning with Moderna's growth potential amid ongoing vaccine demand.
Total AUM
$4.2B
QoQ Performance
N/A
Positions
1
Top 10 Concentration
100.0%
Latest Filing
Q4 2025
Top Holdings Allocation
MDLN
MDLN100.0%
📈 Biggest Buys
MDLN
MEDLINE INC
NEW
100.0% of portfolio
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other100.0%
🚪 Exited Positionssold since Q4 2023
Changes from Q4 2023
NEW1 new position
Historical Filings
Q4 2025Q4 2023